Chinese PE fund manager CICC Capital secures $649m second close of biomedicine fund

Chinese PE fund manager CICC Capital secures $649m second close of biomedicine fund

12 January, 2021

biomedicine CICC Capital CICC Qide CICC Qide Innovation Biopharmaceutical Equity Investment Fund

Printed by Unregistered user on Mon, 08 Dec 2025 18:13:04 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Carlyle leads $123m round in Shanghai-based biopharma firm Abbisko

Venture Capital

Chinese biopharma firm Pegbio nets $122m in pre-IPO round from YF Capital, Yingke, others

Read more from Greater China

Climate Tech & ESG

Chinese firms committed $80b to overseas cleantech investments in past year: report

IDG, others pour over $141m into Chinese new materials maker Xingi